Related Experiment Video
Updated: Jul 26, 2026

On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
Endothelial dysfunction in Fabry disease: retinal biomarkers link cardiac GLA gene variants with chronic inflammation
Timon Wallraven1, Claudia Regenbogen1, Roman Günthner1
1TUM School of Medicine and Health, Department of Nephrology, TUM University Hospital, Technical University of Munich, Munich, Germany.
Insights
Retinal Vessel Analysis (RVA) can detect microvascular endothelial dysfunction in Fabry disease (FD) patients. This non-invasive method may help identify individuals at risk for cardiac complications, aiding in cardiovascular risk stratification.
Area of Science:
- Ophthalmology
- Genetics
- Cardiology
Background:
- Fabry disease (FD) is an X-linked lysosomal storage disorder stemming from alpha-galactosidase A gene (GLA) variants.
- Cardiac complications are a primary cause of mortality in FD, yet identifying at-risk patients is challenging due to numerous GLA variants.
Purpose of the Study:
- To assess microcirculation in FD patients using Retinal Vessel Analysis (RVA).
- To investigate associations between RVA parameters, cardiac involvement, and specific GLA variants.
- To evaluate RVA as a non-invasive biomarker for cardiovascular risk stratification in FD.
Main Methods:
- Retinal Vessel Analysis (RVA) was performed on 63 FD patients and 60 age- and gender-matched healthy controls.
- Parameters analyzed included venular dilation, arteriolar caliber, and arteriolar-to-venular ratio.
- Associations between RVA findings, cardiac status, GLA variants, inflammation, and endothelial dysfunction (ED) were examined.
Main Results:
- FD patients exhibited reduced venular flicker-induced dilation, narrower retinal arterioles, and a lower arteriolar-to-venular ratio compared to controls.
- Impaired retinal microcirculation correlated with cardiac involvement and was more pronounced in patients with cardiac-associated GLA variants.
- FD patients showed elevated markers of inflammation and endothelial dysfunction, which correlated with altered retinal microcirculation.
Conclusions:
- Retinal Vessel Analysis (RVA) effectively detects microvascular endothelial dysfunction in Fabry disease.
- RVA parameters are associated with cardiac involvement and specific GLA variants in FD patients.
- RVA shows promise as a non-invasive tool for cardiovascular risk stratification in Fabry disease.
Abstract:
Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by variants in the alpha-galactosidase A gene (GLA). Cardiac complications are a major cause of mortality, but the large number of variants complicate early identification of at-risk patients. In this study, we assessed the microcirculation using Retinal Vessel Analysis (RVA) in 63 FD patients age- and gender-matched to 60 healthy controls, analyzing associations between RVA parameters, cardiac involvement, and GLA variants. FD patients showed reduced venular flicker-induced dilation, narrower retinal arterioles, and a lower arteriolar-to-venular ratio. Impaired retinal microcirculation was associated with cardiac involvement, and patients with cardiac-associated GLA variants exhibited narrower retinal arterioles. Markers of inflammation and endothelial dysfunction (ED) were significantly higher in FD patients. Higher inflammatory levels correlated with altered retinal microcirculation in patients carrying cardiac-associated GLA variants. RVA detects microvascular ED in FD patients and may serve as a non-invasive biomarker for cardiovascular risk stratification. Registration: https://clinicaltrials.gov/study/NCT06758648 ; Unique identifier: NCT06758648.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
06:09Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Diabetic Retinopathy
Multiple Sclerosis l: Introduction